Are Analysts Bullish about Indivior PLC (LON:INDV) after last week?

October 13, 2017 - By Marguerite Chambers

 Are Analysts Bullish about Indivior PLC (LON:INDV) after last week?

Indivior PLC (LON:INDV) Ratings Coverage

Among 8 analysts covering Indivior Plc (LON:INDV), 6 have Buy rating, 0 Sell and 2 Hold. Therefore 75% are positive. Indivior Plc had 98 analyst reports since July 29, 2015 according to SRatingsIntel. Deutsche Bank maintained it with “Buy” rating and GBX 240 target in Wednesday, April 20 report. The firm earned “Buy” rating on Friday, September 1 by Numis Securities. The stock has “Buy” rating by Jefferies on Friday, August 11. The firm earned “Buy” rating on Friday, February 3 by Numis Securities. The company was downgraded on Tuesday, July 19 by Citigroup. The stock of Indivior PLC (LON:INDV) earned “Buy” rating by Stifel Nicolaus on Thursday, December 10. The company was maintained on Friday, June 24 by Stifel Nicolaus. The firm has “Buy” rating given on Monday, February 8 by Deutsche Bank. The company was maintained on Thursday, May 4 by Jefferies. On Wednesday, June 8 the stock rating was maintained by Jefferies with “Buy”. Below is a list of Indivior PLC (LON:INDV) latest ratings and price target changes.

08/09/2017 Broker: Jefferies Rating: Buy Old Target: GBX 540.00 New Target: GBX 358.00 Maintain
05/09/2017 Broker: Citigroup Rating: Neutral Old Target: GBX 280.00 New Target: GBX 280.00 Maintain
01/09/2017 Broker: Numis Securities Rating: Buy New Target: GBX 470.00 Maintain
11/08/2017 Broker: Jefferies Rating: Buy Old Target: GBX 490.00 New Target: GBX 540.00 Maintain
03/08/2017 Broker: RBC Capital Markets Rating: Outperform New Target: GBX 470.00 Maintain
28/07/2017 Broker: RBC Capital Markets Rating: Outperform Old Target: GBX 390.00 New Target: GBX 470.00 Upgrade
27/07/2017 Broker: Numis Securities Rating: Buy New Target: GBX 490.00 Maintain
11/07/2017 Broker: Numis Securities Rating: Buy Old Target: GBX 490.00 New Target: GBX 490.00 Maintain
07/06/2017 Broker: Jefferies Rating: Buy Old Target: GBX 490.00 New Target: GBX 490.00 Maintain
31/05/2017 Broker: Numis Securities Rating: Buy New Target: GBX 490.00 Maintain

The stock decreased 1.00% or GBX 3.42 on October 13, reaching GBX 337.68. About 1.20M shares traded. Indivior PLC (LON:INDV) has 0.00% since October 13, 2016 and is . It has underperformed by 16.70% the S&P500.

Indivior PLC is a specialty pharmaceutical company. The company has market cap of 2.43 billion GBP. The Firm is engaged in the development, manufacture and sale of buprenorphine prescription drugs for the treatment of opioid dependence (the Indivior Business). It has a 47.73 P/E ratio. The Company’s treatment and pipeline focus is opioid use disorder, alcohol use disorder, overdose rescue and central nervous system (CNS) disorders/schizophrenia.

More notable recent Indivior PLC (LON:INDV) news were published by: Prnewswire.com which released: “Indivior PLC Announces FDA Acceptance with Priority Review Designation of RBP …” on July 31, 2017, also Seekingalpha.com with their article: “Indivior Treads Forward In Opioid Addiction Market” published on June 06, 2017, Prnewswire.com published: “Indivior PLC Presents Results from the Phase 3 Pivotal Study of RBP-6000 …” on June 21, 2017. More interesting news about Indivior PLC (LON:INDV) were released by: Prnewswire.com and their article: “DURECT and Indivior PLC Sign a $17.5 Million Patent Purchase Agreement” published on October 02, 2017 as well as Seekingalpha.com‘s news article titled: “Indivior Could Fall Further Once Generic Suboxone Arrives” with publication date: September 12, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.